Document is current
Any future updates will be listed below
-
Authors
Madhukar, Neel S. https://orcid.org/0000-0002-2907-2062
Khade, Prashant K.
Huang, Linda
Gayvert, Kaitlyn https://orcid.org/0000-0001-9135-6501
Galletti, Giuseppe
Stogniew, Martin
Allen, Joshua E.
Giannakakou, Paraskevi
Elemento, Olivier
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U24CA210989, P50CA211024)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 20 June 2018
Accepted: 10 October 2019
First Online: 19 November 2019
Competing interests
: O.E. and N.S.M are co-founders and equity holders in One Three Biotech, Inc, a company that may use some of the methods described in this article for commercial purpose. O.E. and N.S.M. have filed a patent application on the Bayesian data integrative computational method for predicting binding targets of chemicals (BANDIT) described in this article (US Patent App. 16/315,625). J.E.A. and M.S. are employees and shareholders of Oncoceutics. The remaining authors declare no competing interests.
